Breaking News Instant updates and real-time market news.

FLDM

Fluidigm

$4.47

-0.185 (-3.97%)

17:09
10/14/16
10/14
17:09
10/14/16
17:09

Levin Capital reports 25.2% stake in Fluidigm

The Reporting Persons purchased the Shares based on the Reporting Persons' belief that the Shares, when purchased, were undervalued and represented an attractive investment opportunity. The Reporting Persons remain passive investors in the Issuer and are filing the Schedule 13D as a result of acquiring over 20% of the outstanding Shares of the Issuer.

  • 29

    Nov

FLDM Fluidigm
$4.47

-0.185 (-3.97%)

03/18/16
MZHO
03/18/16
NO CHANGE
MZHO
Thermo Fisher has room to raise Affymetrix bid, says Mizuho
Mizuho analyst Eric Criscuolo thinks Thermo Fisher (TMO) has room to counter Origin Technologies' offer for Affymetrix (AFFX) and it still be a good acquisition. If Thermo raises its bid, even to something "modestly above" $16.10 per share, the takeover valuation would still be "reasonable," Criscuolo tells investors in a research note after Origin announced a bid of $16.10 per share for Affymetrix. Other companies that could receive buyout attention should Thermo walk away include Fluidigm (FLDM), Luminex (LMNX) and NanoString (NSTG), the analyst contends.
04/01/16
LEER
04/01/16
NO CHANGE
Target $20
LEER
Outperform
Fluidigm remains top micro-cap pick at Leerink
Leerink analyst Dan Leonard says Fluidigm remains top micro-cap pick, following his MEDACorp survey of next-generation sequencing lab directors that offered some "incremental comfort" on the company's key single cell products and supported his long-term thinking. Leonard believes Fluidigm's business can return to double-digit organic growth in 2016 and revenue acceleration could lead to multiple expansion. The analyst reiterates an Outperform rating and $20 price target on the shares.
04/12/16
LEER
04/12/16
NO CHANGE
Target $15
LEER
Outperform
Fluidigm price target lowered to $15 from $20 at Leerink
Leerink analysts led by Dan Leonard lowered Fluidigm's price target to $15 from $20 following the company's disclosure that the new 800 cell chip for medium-sized cells on its C1 instrument is now a Q4 event, and not a Q2 event as previously thought. Leonard said he is increasingly "wary" that the launch of ultra-high throughput, 10,000 cell chip is a 2017 event. The analyst maintains an Outperform rating on Fluidigm shares.
10/13/16
CANT
10/13/16
NO CHANGE
CANT
Fluidigm outlook still positive, says Cantor
After Fludigm reported weaker than expected results, Cantor analyst Bryan Brokmeier is "concerned that the company may be seeing continued weakness in both BioMark and C1 instrument sales," and he thinks that the C1 and Applied businesses may be suffering from low utilization rates. .Brokmeier cut his price target on the stock to $9 from $11, but he continues to believe that the company can obtain a "significant share of the rapidly growing single-cell biology market over the next three to five years." The analyst thinks that the company can turn itself around soon ,and he keeps a Buy rating on the shares.

TODAY'S FREE FLY STORIES

X

U.S. Steel

$22.02

0.951 (4.51%)

11:40
06/23/17
06/23
11:40
06/23/17
11:40
Options
Active trading in US Steel expiring at-the-money calls »

Active trading in US…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:40
06/23/17
06/23
11:40
06/23/17
11:40
General news
St. Louis Fed hawk-dove Bullard was quite dovish »

St. Louis Fed hawk-dove…

INFY

Infosys

$14.84

0.065 (0.44%)

11:34
06/23/17
06/23
11:34
06/23/17
11:34
Hot Stocks
Infosys reports auditors found no evidence of wrongdoing »

Infosys announced earlier…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INFY

Infosys

$14.84

0.065 (0.44%)

11:31
06/23/17
06/23
11:31
06/23/17
11:31
Hot Stocks
NY AG Schneiderman announces $1M settlement with Infosys »

New York Attorney General…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WDC

Western Digital

$90.25

-0.78 (-0.86%)

11:25
06/23/17
06/23
11:25
06/23/17
11:25
Options
Western Digital call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VLKAY

Volkswagen

$30.88

0.6 (1.98%)

11:22
06/23/17
06/23
11:22
06/23/17
11:22
Periodicals
VW reducing workforce at core unit more quickly than planned, Reuters says »

Volkswagen is cutting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PTLA

Portola Pharmaceuticals

$38.25

-1.24 (-3.14%)

11:18
06/23/17
06/23
11:18
06/23/17
11:18
Hot Stocks
Breaking Hot Stocks news story on Portola Pharmaceuticals »

Portola Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jun

  • 24

    Jun

$NSD

NASDAQ Market Internals

11:17
06/23/17
06/23
11:17
06/23/17
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

11:16
06/23/17
06/23
11:16
06/23/17
11:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VALE

Vale

$8.22

0.12 (1.48%)

11:10
06/23/17
06/23
11:10
06/23/17
11:10
Options
10K VALE Jan 10 calls trade at 40c on ISE »

10K VALE Jan 10 calls…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NURO

NeuroMetrix

$2.89

0.056 (1.98%)

11:08
06/23/17
06/23
11:08
06/23/17
11:08
Hot Stocks
NeuroMetrix provides update on Quell wearable pain relief clinical program »

NeuroMetrix provided an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAT

Caterpillar

$103.76

-0.08 (-0.08%)

11:08
06/23/17
06/23
11:08
06/23/17
11:08
Hot Stocks
As bar gets raised Deutsche Bank gets less bullish on Caterpillar »

Deutsche Bank downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HZNP

Horizon Pharma

$11.87

0.44 (3.85%)

11:04
06/23/17
06/23
11:04
06/23/17
11:04
Earnings
Horizon Pharma now sees FY17 net sales $985M-$1.02B, consensus $990.53M »

In May, Horizon lowered…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HZNP

Horizon Pharma

$11.87

0.44 (3.85%)

11:02
06/23/17
06/23
11:02
06/23/17
11:02
Hot Stocks
Horizon Pharma completes sale of European marketing rights for Procysbi »

Horizon Pharma announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UUP

PowerShares DB US Dollar Index Up

$25.14

-0.09 (-0.36%)

11:00
06/23/17
06/23
11:00
06/23/17
11:00
Options
Large spread in UPS as shares deliver gains »

Large spread in UPS as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:00
06/23/17
06/23
11:00
06/23/17
11:00
General news
Breaking General news story  »

St. Louis Federal Reserve…

10:55
06/23/17
06/23
10:55
06/23/17
10:55
General news
Euro$ interest rate futures are marginally lower »

Euro$ interest rate…

NVO

Novo Nordisk

$44.13

0.46 (1.05%)

10:52
06/23/17
06/23
10:52
06/23/17
10:52
Hot Stocks
Novo Nordisk reports up to 13.8% weight loss in people receiving semaglutide »

Novo Nordisk announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UPS

UPS

$110.54

1.469 (1.35%)

10:45
06/23/17
06/23
10:45
06/23/17
10:45
Options
UPS call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jul

WMGI

Wright Medical

$26.99

0.11 (0.41%)

10:45
06/23/17
06/23
10:45
06/23/17
10:45
Conference/Events
Wright Medical has a conference call hosted by JPMorgan »

JPMorgan Analyst Hanover…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jun

  • 26

    Jun

  • 28

    Jun

  • 03

    Jul

WDC

Western Digital

$90.25

-0.78 (-0.86%)

10:40
06/23/17
06/23
10:40
06/23/17
10:40
Technical Analysis
Technical View: Western Digital trades higher as Toshiba indicates open to talks »

The stock was last up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNCR

Synchronoss

$12.18

1.53 (14.37%)

10:31
06/23/17
06/23
10:31
06/23/17
10:31
Hot Stocks
Synchronoss confirms receipt of Siris Capital indication of interest »

Synchronoss Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TGT

Target

$50.81

0.175 (0.35%)

10:31
06/23/17
06/23
10:31
06/23/17
10:31
Periodicals
Target starts removing all Hampton Creek products from stores, Bloomberg reports »

Target is voluntarily…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:30
06/23/17
06/23
10:30
06/23/17
10:30
General news
The 2.9% May U.S. new home sales rise »

The 2.9% May U.S. new…

YY

YY

$58.32

-0.66 (-1.12%)

10:28
06/23/17
06/23
10:28
06/23/17
10:28
Conference/Events
YY management to meet with Jefferies »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.